• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

How Preferred-Language Communication Improves Care and the Patient Experience

Article

Sponsored Resources

How Preferred-Language Communication Improves Care and the Patient Experience

Language barriers result in poor communication and experiences for patients and providers alike. Plus, patients with limited English proficiency (LEP) are more likely to need more healthcare services and to experience higher rates of adverse medical events.

However, there are simple steps healthcare organizations can take to make preferred-language communication easier for patients and providers. When organizations use patients’ language of preference, staff are more efficient and feel more supported while patients receive more personalized care and have better experiences.

Read this white paper to learn:
• The impact of communicating with patients in their preferred language
• How preferred-language communication improves patients’ access to care
• How technology breaks down language barriers to improve care and meet patients where they are

Complete the form below to learn more.

Sponsored By:

Phreesia
© 2024 MJH Life Sciences

All rights reserved.